Press-release for stocks related to therapeutics

Prices are updated after-hours

tags : Therapeutics

save search

Spyre Therapeutics Announces $180 Million Private Placement
Published: 2023-12-07 (Just crawled : 00:00) - prnewswire.com
AGLE | $12.01 8.79% 8.38% 43K

Health Technology

| Email alert Add to watchlist
therapeutics

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-12-07 (Crawled : 22:00) - globenewswire.com
FULC | News | $4.945 6.8% 6.37% 280K

Health Technology

| Email alert Add to watchlist
nasdaq grants therapeutics

Aligos Therapeutics Presents Positive Clinical Data at Hep-DART 2023 from Phase 1 Studies in HBV (ALG-000184) and NASH (ALG-055009)
Published: 2023-12-07 (Crawled : 21:00) - globenewswire.com
ALGS | News | $0.6475 -5.06% 26.67% 2.1M

Health Technology

| Email alert Add to watchlist
alg-0001 positive therapeutics nash

ZyVersa Therapeutics Announces Publication Demonstrating That Plasma Levels of NLRP3 Inflammasomes Correlate with Progression of Diabetic Kidney Disease in Patients with Type 2 Diabetes
Published: 2023-12-07 (Crawled : 17:00) - globenewswire.com
ZVSA | News | $1.1 -48.6% -94.55% 4.4M

| 0.0% | O: -58.28% H: 0.0% C: 0.0%
disease kidney publication therapeutics diabetes diabetic

Antibody Therapeutics Market Worth $479.0 Billion | MarketsandMarkets
Published: 2023-12-07 (Crawled : 15:30) - prnewswire.com
NVS | News | $95.93 -1.15% 0.0% 1.2M

Health Technology

| 0.0% | O: -1.58% H: 0.0% C: 0.0%
JNJ | News | $155.4 -0.78% -0.02% 6.4M

Health Technology

| 0.0% | O: -1.61% H: 0.0% C: 0.0%
ABBV | News | $147.97 1.09% 0.05% 7.2M

Health Technology

| 0.0% | O: 1.97% H: 0.0% C: 0.0%
SNY | News | $46.06 0.17% 0.17% 1.9M

Health Technology

| 0.0% | O: -1.19% H: 0.0% C: 0.0%
REGN | News | $849.57 1.65% 1.63% 560K

Health Technology

| -0.62% | O: 1.63% H: 0.0% C: 0.0%
IMNM | News A | $7.715 -1.59% -1.62% 120K

Health Technology

| 0.0% | O: -0.26% H: 0.0% C: 0.0%
BIIB | News | $239.14 2.25% 2.2% 1.2M

Health Technology

| 0.0% | O: 3.35% H: 0.0% C: 0.0%
antibody therapeutics market

BrainStorm Cell Therapeutics Announces Outcome of FDA Meeting on NurOwn® in ALS
Published: 2023-12-07 (Crawled : 13:30) - prnewswire.com
BCLI | News | $0.2234 -24.86% -33.08% 6M

Health Technology

| 0.0% | O: -15.25% H: 0.0% C: 0.0%
nurown fda als cell meeting therapeutics

Cidara Therapeutics Presents New Promising Preclincal Data on Novel Dual-Acting Drug-Fc Conjugates at ESMO Immuno-Oncology Annual Congress
Published: 2023-12-07 (Crawled : 13:00) - globenewswire.com
CDTX | News | $0.7331 -3.41% -3.53% 540K

Health Technology

| 0.0% | O: -1.25% H: 0.0% C: 0.0%
congress therapeutics

Xilio Therapeutics Announces Initiation of Enrollment for Phase 1 Combination Trial of XTX101, a Tumor-Activated, Fc-Enhanced Anti-CTLA-4, and Updated Phase 1 Monotherapy Data
Published: 2023-12-07 (Crawled : 12:30) - globenewswire.com
XLO | News | $0.8801 -0.01% 10K

Professional, Scientific, and T...

| Email alert Add to watchlist
xtx101 trial therapeutics

Kymera Therapeutics Announces First Patient Dosed in Phase 2 Atopic Dermatitis Clinical Trial of KT-474 (SAR444656), a First-in-Class, Investigational IRAK4 Degrader, Generating a $15 Million Payment from Sanofi
Published: 2023-12-07 (Crawled : 12:00) - globenewswire.com
SNY | News | $46.06 0.17% 0.17% 1.9M

Health Technology

| 0.0% | O: -1.19% H: 0.0% C: 0.0%
KYMR | News | $23.68 7.2% 6.71% 1.1M

Health Technology

| -3.78% | O: 4.06% H: 0.0% C: 0.0%
kt-474 first dermatitis payment trial therapeutics sanofi

Axsome Therapeutics Hosts Solriamfetol Virtual Investor Event with Expert Thought Leaders Today
Published: 2023-12-07 (Crawled : 12:00) - globenewswire.com
AXSM | News | $70.22 1.26% 1.24% 630K

Health Technology

| -0.16% | O: -0.36% H: 0.0% C: 0.0%
therapeutics solriamfetol today

TScan Therapeutics Appoints R. Keith Woods to its Board of Directors, Bringing Expertise in Commercialization and Global Operations
Published: 2023-12-07 (Crawled : 12:00) - globenewswire.com
TCRX | News | $6.68 -0.89% -0.9% 96K

Professional, Scientific, and T...

| 0.6% | O: 0.22% H: 0.0% C: 0.0%
global commercialization therapeutics

CERE MERGER ANNOUNCEMENT: Julie & Holleman LLP Announces Investigation Into Potential Claims Regarding AbbVie's Proposed Acquisition of Cerevel Therapeutics
Published: 2023-12-07 (Crawled : 05:00) - prnewswire.com
ABBV | News | $147.97 1.09% 0.05% 7.2M

Health Technology

| 0.0% | O: 1.97% H: 0.0% C: 0.0%
CERE | News | $41.085 11.25% 10.11% 31M

Finance

| 0.0% | O: 12.64% H: 0.0% C: 0.0%
acquisition therapeutics potential

AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
Published: 2023-12-06 (Crawled : 22:00) - prnewswire.com
MS | News | $80.35 1.18% -0.03% 5.3M

Finance

| 0.0% | O: -0.56% H: 0.0% C: 0.0%
ABBV | News | $147.97 1.09% 0.05% 7.2M

Health Technology

| 0.0% | O: 1.97% H: 0.0% C: 0.0%
CERE | News | $41.085 11.25% 10.11% 31M

Finance

| 0.0% | O: 12.64% H: 0.0% C: 0.0%
abbvie pipeline acquire therapeutics

Voyager Therapeutics Announces Selection of Development Candidate for SOD1 Amyotrophic Lateral Sclerosis Gene Therapy Program- IND filing expected in mid-2025 -
Published: 2023-12-06 (Crawled : 20:00) - biospace.com/
VYGR | $7.85 3.15% 3.06% 180K

Health Technology

| 2.16% | O: 2.16% H: 0.0% C: 0.0%
SGMO | $0.443 -1.14% -1.15% 850K

Health Technology

| -4.81% | O: -4.81% H: 0.0% C: 0.0%
NBIX M | $119.97 0.42% 0.42% 880K

Health Technology

| 3.02% | O: 3.02% H: 0.0% C: 0.0%
candidate expected sclerosis therapeutics therapy

Parkinson's Disease Therapeutics Market revenue to hit USD 12.32 Billion by 2033, Says We Market Research
Published: 2023-12-06 (Crawled : 15:30) - prnewswire.com
NVS | News | $95.93 -1.15% 0.0% 1.2M

Health Technology

| 0.17% | O: 0.17% H: 0.0% C: 0.0%
GSK | $36.0 -0.47% 0.06% 2.2M

Health Technology

| 0.03% | O: 0.03% H: 0.0% C: 0.0%
LLY | $588.27 -0.17% -0.1% 2.1M

Health Technology

| 0.99% | O: 0.99% H: 0.0% C: 0.0%
ABBV | News | $147.97 1.09% 0.05% 7.2M

Health Technology

| 0.26% | O: 0.26% H: 0.0% C: 0.0%
DNLI | $18.72 -2.19% -2.24% 1.1M

Health Technology

| -0.22% | O: -0.22% H: 0.0% C: 0.0%
BIIB | News | $239.14 2.25% 2.2% 1.2M

Health Technology

| 0.46% | O: 0.46% H: 0.0% C: 0.0%
disease parkinson's revenue research therapeutics market

CARGO Therapeutics Announces Scientific Advisory Board
Published: 2023-12-06 (Crawled : 15:30) - biospace.com/
CRGX | $16.0 7.67% 7.13% 92K

| 2.71% | O: 2.71% H: 0.0% C: 0.0%
therapeutics

Coya Therapeutics Announces $26.5 Million Private Placement
Published: 2023-12-06 (Crawled : 14:30) - biospace.com/
COYA | $7.27 0.41% 0.41% 64K

| -6.04% | O: -6.04% H: 0.0% C: 0.0%
therapeutics

NAYA Biosciences and ONK Therapeutics Announce Research Partnership to Advance Combination Therapy of FLEX-NK™ Bispecific Antibodies and Optimally Engineered Off-the-Shelf Natural Killer Cell Therapies
Published: 2023-12-06 (Crawled : 14:30) - invobioscience.com
INVO | $1.53 -6.71% -7.19% 240K

Health Technology

| 3.77% | O: 3.77% H: 0.0% C: 0.0%
partnership natural cell research therapeutics therapy

Cidara Therapeutics Announces Completion of Enrollment in Phase 3 Restore Trial of Rezafungin in China
Published: 2023-12-06 (Crawled : 13:00) - globenewswire.com
CDTX | News | $0.7331 -3.41% -3.53% 540K

Health Technology

| -4.19% | O: -4.19% H: 0.0% C: 0.0%
rezafungin trial therapeutics china

Outlook Therapeutics® Announces Strategic Organizational Realignment
Published: 2023-12-06 (Crawled : 13:00) - globenewswire.com
OTLK | News | $0.4443 -0.16% -0.16% 870K

Health Technology

| -0.9% | O: -0.9% H: 0.0% C: 0.0%
therapeutics